Natixis’s Esperion Therapeutics ESPR Stock Holding History

Natixis’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,424	Closed	-$689K	–	797
2020 Q2	$689K	Buy	+13,424	New	+$562K	0.01%	568
2020 Q1	–	Sell	-8,407	Closed	-$503K	–	753
2019 Q4	$503K	Buy	8,407 +876	+12%	+$39.4K	﹤0.01%	714
2019 Q3	$276K	Sell	7,531 -14,032	-65%	-$556K	﹤0.01%	744
2019 Q2	$1M	Buy	21,563 +9,095	+73%	+$427K	0.01%	534
2019 Q1	$500K	Sell	12,468 -9,579	-43%	-$430K	﹤0.01%	664
2018 Q4	$1.01M	Buy	22,047 +14,439	+190%	+$696K	0.01%	510
2018 Q3	$338K	Sell	7,608 -436	-5%	-$20K	﹤0.01%	675
2018 Q2	$315K	Sell	8,044 -835	-9%	-$42.2K	﹤0.01%	755
2018 Q1	$642K	Sell	8,879 -1,198	-12%	-$88K	﹤0.01%	644
2017 Q4	$663K	Buy	+10,077	New	+$543K	0.01%	559

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return